Flynn Patrick John (CIK 0001864871)

Latest company ownership

Shares held
1,750
Last filed at
Nov 29, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 28, 2022 Nov 29, 2022 NRX Pharmaceuticals, Inc. Director Buy 86.3 +11,750 8.06% $14.7K